Purity ≥ 99%Synthetic peptide analog
GLP-3 (RT)
Analytical-grade peptide reference material, supplied as a lyophilized powder for in-vitro laboratory research use only.
Free shipping over $149 · CoA included with every order
Est. 2-5 days
Free shipment protection
Overnight shipping available
Secure checkout · cards processed by our payment provider
Lab Tested by Vanguard · Certificate of Analysis per lot
GLP-3 (RT)
GLP-3 (RT) is supplied as an analytical-grade biochemical reference material for laboratory research use only.
Intended use
Supplied for in-vitro research, analytical method development, identity verification, and laboratory evaluation by qualified research customers.
Documentation
Lot-level documentation and a Certificate of Analysis (identity, purity, and concentration) are matched to the exact lot and available for review.
Restrictions
Not for human or animal consumption. Not for therapeutic, clinical, diagnostic, dietary-supplement, dosing, injection, ingestion, or administration use.
By ordering, the buyer confirms qualified research use and agrees not to use the material for human or animal consumption or administration. Refrigerate upon receipt; keep in a dark environment.
Published research
Selected peer-reviewed literature
Independent published studies on this compound, listed for research reference only. These citations are not claims of any effect; VNG materials are supplied for laboratory research use.
Retatrutide for obesity — Phase 2 trial
The New England journal of medicine · PubMed ↗
Retatrutide in obesity pharmacotherapy
Biomolecules · PubMed ↗
Retatrutide in obesity and diabetes therapy
European journal of pharmacology · PubMed ↗
Retatrutide for type 2 diabetes — Phase 2 trial
Lancet (London, England) · PubMed ↗
Retatrutide for fatty liver disease — Phase 2a trial
Nature medicine · PubMed ↗
Retatrutide for obesity — systematic review & meta-analysis
Proceedings (Baylor University. Medical Center) · PubMed ↗
Retatrutide on weight & metabolic markers — meta-analysis
Metabolism open · PubMed ↗
Retatrutide — TRIUMPH clinical trial program
Diabetes, obesity & metabolism · PubMed ↗
Retatrutide and body composition in type 2 diabetes — Phase 2
The lancet. Diabetes & endocrinology · PubMed ↗
Retatrutide for obesity — review of clinical trials
Journal of basic and clinical physiology and pharmacology · PubMed ↗
Research stack
Frequently researched together
Reference materials commonly studied alongside GLP-3 (RT) in the published literature. Add the stack to your research order in one step. Supplied for laboratory research use only.
More peptides for research
Other analytical-grade reference materials from the VNG catalog.
